The U-S will pay nearly 2-billion dollars for Pfizer to produce and deliver 100 million doses of its Covid-19 vaccine candidate in the U.S. if it proves safe and effective in humans.
German biotech firm BioNTech and Pfizer are developing the vaccine candidate.
The vaccine would be made available to Americans “at no cost,” according to the Health and Human Services secretary. If it proves effective in a large phase three trial and gets regulatory approval, Pfizer will begin to deliver doses at the government’s direction.
Pfizer is producing the vaccine under study at it’s facilities near Kalamazoo, and several other locations.
